NCT07178262 Erector Spinae Block in Reducing Peri-operative Opioid Consumption in Total Abdominal Hystrectomy
| NCT ID | NCT07178262 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Kulsoom International Hospital |
| Condition | Erector Spinae Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2025-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 60 participants in total. It began in 2025-08-01 with a primary completion date of 2025-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hystrectomy is a surgical procedure that involves removal of uterus from the body of patient using a lower abdominal incision. This is an extremely painful procedure which causes discomfort and greatly increases opioids consumption in the peri-operative period. This can be reduced by using nerve blocks such as Erector spinae plane block.
Eligibility Criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) class: I, II and III . * Elective Hysterectomy under General Anesthesia. Exclusion Criteria: * Lack of consent * Body mass index \>35 kg/m2 * Allergic to study medicine * Opioid abuse or misuse disorder * Chronic pain
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07178262 clinical trial?
This trial is open to female participants only, aged 16 Years or older, up to 80 Years, studying Erector Spinae Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07178262 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07178262 currently recruiting?
Yes, NCT07178262 is actively recruiting participants. Contact the research team at waqasanjum435@gmail.com for enrollment information.
Where is the NCT07178262 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07178262 clinical trial?
NCT07178262 is sponsored by Kulsoom International Hospital. The trial plans to enroll 60 participants.